Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
BAJAJHCARE
₹345.50
₹344.85
₹356.00
₹272.35
₹552.60
Markets Today
Historical Performance
As of 10-07-2026 23:17, Bajaj Healthcare Ltd. share price today is ₹0, with a change of ₹-350.10 (-100.00%) from the previous close of ₹350.1. The stock opened at ₹352 and traded between ₹344.85 and ₹356, with a total traded volume of 138630 shares. The company has a market capitalization of ₹1178.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹552.6 and ₹272.35, respectively.
Bajaj Healthcare Ltd. valuation metrics include a P/E ratio of 74.8, and book value of ₹2.20. Profitability indicators show ROE of 2.95% along with a dividend yield of 0.3%. Bajaj Healthcare Ltd. has reported revenue of ₹611.03 Cr and net profit of ₹15.77 Cr.
Bajaj Healthcare Ltd. technical indicators include Day RSI at 63.45, Day MFI at 91.39, Day ADX at 25.15. Additional indicators include Commodity Channel Index (CCI) at 93.2 and Williams %R at -22.83. Momentum indicators show Day MACD at 10.31, Day MACD Signal Line at 8.35, DayATR at 15.38. Rate of Change indicators for Bajaj Healthcare Ltd. include ROC125 at -16.36 and ROC21 at 19.86.
Exponential moving averages include EMA5 at ₹340.8, EMA10 at ₹336.1, EMA12 at ₹334, EMA20 at ₹327.1, EMA26 at ₹323.7, EMA50 at ₹319.7, EMA100 at ₹330.9, EMA200 at ₹365.3. Simple moving averages include SMA5 at ₹339.6, SMA10 at ₹339.4, SMA20 at ₹322.6, SMA30 at ₹313.9, SMA50 at ₹312, SMA100 at ₹319.8, SMA150 at ₹344.8, SMA200 at ₹372.6.
Support levels for Bajaj Healthcare are placed at First Support ₹334.48, Second Support ₹318.87, Third Support ₹305.13. Resistance levels are seen at First Resistance ₹363.83, Second Resistance ₹377.57, Third Resistance ₹393.18. Bajaj Healthcare Ltd. shareholding pattern shows promoter holding at 58.29%, FII holding at 1.98%, DII holding at 0%, public holding at 36.82%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 153.06 | 161.22 | 147.91 | 148.84 | 154.47 |
| Operating Expense | 130.38 | 130.54 | 120.96 | 124.33 | 142.72 |
| Operating Profit | 22.68 | 30.68 | 26.95 | 24.51 | 11.76 |
| Depreciation | 7.63 | 7.20 | 7.08 | 5.64 | 7.53 |
| Interest | 5.57 | 5.88 | 5.56 | 5.23 | 6.08 |
| Tax | -1.40 | 3.14 | 3.51 | 2.35 | 0.13 |
| Net Profit | -22.85 | 15.67 | 11.11 | 11.83 | 11.18 |
₹345.50
↗ Bullish Moving Average
14
↘ Bearish Moving Average
2
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 59.2 | 59.2 | 59.2 | 59.2 | 59.2 | 58.3 |
| FII | 1 | 1 | 1.1 | 1.1 | 1.2 | 2 |
| DII | 2.4 | 2.6 | 3.1 | 3 | 2.9 | 2.9 |
| Public | 37.4 | 37.2 | 36.6 | 36.7 | 36.7 | 36.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.24 L | 5.63 L | 39.83% |
| Week | 1 L | 2.44 L | 41.11% |
| 1 Month | 1.56 L | 10.8 L | 14.42% |
| 6 Month | 99.8 K | 3.56 L | 28.02% |
Benjamin Graham Value Screen
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
RSI indicating price strength
High Volume, High Gain
Biggest Price Gainers from Open
Top Gainers
High Volume, High Gain
Volume Shockers
Insiders bought stocks
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2025 | 1 | FINAL | 19 Sep, 2025 | Equity Share |
| 23 Sep, 2024 | 1 | FINAL | Equity Share | |
| 22 Sep, 2023 | 1 | FINAL | Equity Share | |
| 22 Sep, 2022 | 1.5 | FINAL | Equity Share | |
| 28 Sep, 2021 | 0.5 | FINAL | 29 Sep, 2021 | Equity Share |
| 28 Sep, 2021 | 0.5 | SPECIAL | 29 Sep, 2021 | Equity Share |
| 01 Dec, 2020 | 1.25 | INTERIM | 02 Dec, 2020 | Equity Share |
| 01 Dec, 2020 | 0.5 | SPECIAL | 02 Dec, 2020 | Equity Share |
| 19 Sep, 2018 | 1 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹587.60 | ₹5.40 | ₹179.17 | ₹15.60 | ₹535 | ₹62 |
| % Change | -1.43% | -0.18% | -2.00% | 0.84% | -0.10% | -0.26% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | -1.30 | 47.70 | 29.60 | 26.70 | -103.00 |
| 1 Year Return | 52.07 | 441 | 45.1 | 70 | -25.38 | -41.91 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Solara Active Pharma Sciences Ltd.
₹ 568.90
+0.36%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Dishman Carbogen Amcis Ltd.
₹ 195.49
+1.38%
Lasa Supergenerics Ltd.
₹ 7.52
+1.21%
Advanced Enzyme Technologies Ltd.
₹ 330.00
+1.74%
Ortin Global Ltd.
₹ 16.50
+1.10%
Brooks Laboratories Ltd.
₹ 69.90
-0.87%
RPG Life Sciences Ltd.
₹ 2861.10
+7.69%
Bafna Pharmaceuticals Ltd.
₹ 204.61
+2.00%
Alpa Laboratories Ltd.
₹ 68.70
+0.60%
SMS Pharmaceuticals Ltd.
₹ 403.00
-0.99%
Nectar Lifesciences Ltd.
₹ 11.21
-0.18%
Mangalam Drugs and Organics Ltd.
₹ 27.75
+1.80%
Indoco Remedies Ltd.
₹ 259.00
+1.53%
Ind-Swift Laboratories Ltd.
₹ 247.05
+4.87%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
+0.01%
Panacea Biotec Ltd.
₹ 546.00
-1.66%
Medicamen Biotech Ltd.
₹ 244.00
-0.57%
Themis Medicare Ltd.
₹ 117.59
+1.33%
By signing up I certify terms, conditions & privacy policy